Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis.
Melissa C MacKinnonJ M SargeantD L PearlR J Reid-SmithC A CarsonE J ParmleyS A McEwenPublished in: Antimicrobial resistance and infection control (2020)
Overall, resistant E. coli infections were associated with significant 30-day and all-cause mortality burden. More research and/or improved reporting are necessary to facilitate quantitative syntheses of bacterium-attributable mortality, length of hospital stay, and hospital costs. Protocol Registration PROSPERO CRD42018111197.
Keyphrases
- escherichia coli
- healthcare
- adverse drug
- risk factors
- public health
- randomized controlled trial
- acute care
- staphylococcus aureus
- mental health
- high resolution
- type diabetes
- cardiovascular disease
- health information
- klebsiella pneumoniae
- multidrug resistant
- mass spectrometry
- climate change
- candida albicans
- social media
- human health